DLL3-SAVVYZ-IL18 CAR T cell therapy
/ Memorial Sloan-Kettering Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 03, 2026
A Study of Armored CAR T Cells in People With Cancer
(clinicaltrials.gov)
- P1 | N=16 | Recruiting | Sponsor: Memorial Sloan Kettering Cancer Center | Not yet recruiting ➔ Recruiting
Enrollment open • Endocrine Cancer • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor • DLL3 • IL18
August 25, 2026
A Study of Armored CAR T Cells in People With Cancer
(clinicaltrials.gov)
- P1 | N=16 | Not yet recruiting | Sponsor: Memorial Sloan Kettering Cancer Center
New P1 trial • Endocrine Cancer • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor • DLL3 • IL18
1 to 2
Of
2
Go to page
1